Challenges in Dosing Low Molecular Weight Heparin

Faculty

Joseph F. Dasta, MSc., FCCM, FCCP
Professor, Division of Pharmacy Practice and Administration
College of Pharmacy The Ohio State University

Joseph F. Dasta, MS, FCCM, FCCP is Professor of Pharmacy Practice at The Ohio State University College of Pharmacy He earned his Master of Science in hospital pharmacy from The Ohio State University College of Pharmacy. Mr. Dasta completed a residency at The Ohio State University Hospital. He received an American Society of Health-Systems Pharmacists Research and Education Foundation grant in 1998 for his work in medication errors and adverse drug events in the intensive care unit (ICU).

An invited lecturer on a national level, Mr. Dasta has lectured on topics such as pharmacoeconomic issues in critical care; pharmacotherapy of severe sepsis; hemoglobin management in acute care; critical care pharmacy development; and sedation, analgesia, and neuromuscular blockade in the ICU. His research initiatives include use of bispectral index in the ICU; cost analysis of erythropoietic stimulating proteins, epidemiology, and costs of acute heart failure; costs are resource of acute renal failure; and an international survey of hospital pharmacy and critical care pharmacy practice. He is a fellow of the American College of Critical Care Medicine and the American College of Clinical Pharmacy.

A recipient of the 2002 Education Award from the American College of Clinical Pharmacy, Mr. Dasta was recently honored by the Society of Critical Care Medicine by having a pharmacy outcomes research grant in his name. In 2005, Professor Dasta was the recipient of the Society of Critical Care Medicine Distinguished Service Award. Professor Dasta has trained ten fellows and 10 residents in critical care pharmacy. He has given over 200 regional or national lectures, authored or co-authored over 100 refereed manuscripts and book chapters and has written 100 abstracts and brief communications. He is an editorial board member for Critical Care Medicine and Annals of Pharmacotherapy.

Steven M. Hollenberg, MD
Director, Coronary Care Unit
Cooper University Hospital
Professor of Medicine
Robert Wood Johnson Medical School/ UMDNJ-Camden

Steve Hollenberg is a professor of medicine at Robert Wood Johnson Medical School/UMDNJ and director of the coronary care unit at Cooper University Hospital in Camden, NJ. He attended Amherst College and Emory University School of Medicine, and trained in internal medicine at New York Hospital, in critical care medicine at the National Institutes of Health, and in cardiology at Johns Hopkins Hospital. Research interests relate to endothelial and myocardial function, with emphases on atherosclerosis and the pathophysiology of shock. In the laboratory, in vivo videomicroscopy, echocardiography, and implantable radiotelemetry are performed in a murine model. Clinical research interests include endothelial function on both the macrovascular and microvascular level, and vascular stiffness. Current clinical investigations include assessment of endothelial dysfunction and vascular compliance in patients with subclinical coronary artery disease using brachial artery ultrasonography, pulse wave velocity, and radial waveform analysis, and microvascular assessment in patients with shock using orthogonal polarization spectral imaging.

Sandra L. Kane-Gill, PharmD., MSc.
Assistant Professor, Pharmacy and Therapeutics
University of Pittsburgh School of Pharmacy

Sandra L. Kane-Gill, PharmD, MSc received her baccalaureate pharmacy degree from Wayne State University in 1994. She completed an ASHP accredited pharmacy practice residency at West Virginia University Hospital in 1996. In 1998 she received her Doctorate of Pharmacy from the University of Toledo. Dr. Kane-Gill then pursued her Masters of Science in Pharmacy Administration with emphasis on Pharmacoeconomics and Health Outcomes at the Ohio State University in Columbus, Ohio from 1999-2001. Between 1998-2001 she completed her Critical Care Fellowship at the Ohio State University Upon completion of her training she joined the faculty of the University of Pittsburgh, School of Pharmacy in 2001 with an appointment as Assistant Professor in the Department of Pharmacy and Therapeutics for the Center for Pharmacoinformatics and Outcomes Research.

Dr. Kane-Gill’s research interests focus on economic, clinical and humanistic evaluations for critically ill patients; specifically patient safety, quality of life in patients receiving sedatives/neuromuscular blockers, and developing models of cost for acute illness. She has served as Principal Investigator and Co-Investigator on several funded research grants in this area of study. Her research projects spanned the areas of infectious diseases, anticoagulation, antidysrhythmics, sedation and adverse drug events. Her work has been presented as both oral and poster presentations at several national and international professional meetings including the Society of Critical Care Medicine (SCCM), European Society of Intensive Care Medicine, Annual American Society of Health-System Pharmacists (ASHP), American College of Clinical Pharmacy (ACCP), as well as local professional meetings.

Arthur P. Wheeler, MD
Associate Preprocessor Division of Allergy, Pulmonary & Critical Care Medicine
Vanderbilt University School of Medicine

Dr. Wheeler is an Associate Professor in the Division of Allergy, Pulmonary and Critical Care Medicine at Vanderbilt University. He is a graduate of the University of Maryland School of Medicine then completed training programs in Internal Medicine, Pulmonary Disease and Critical Care at Vanderbilt University.

He is a member of the American Thoracic Society, Society of Critical Care Medicine, and American Federation for Clinical Research and is a Fellow of the American College of Chest Physicians. His research in sepsis, thromboembolic disease, and acute lung injury has resulted in more than 100 publications. He is the co-author of a successful textbook of Critical Care Medicine now in its third edition. Dr. Wheeler has delivered hundreds of National and International lectures and is the recipient of numerous teaching awards. He currently serves as the Director of the Vanderbilt ICU.

Disclosure Policy
It is the policy of ArcMesa Educators to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/authors participating in our programs are expected to disclose any relationships they may have with commercial companies whose products and services may be mentioned so that participants may evaluate the objectivity of the presentations.

Faculty Disclosure Declarations
Joseph F. Dasta, MSc., FCCM, FCCP– Nothing to disclose

Steven M. Hollenberg, MD– Nothing to disclose

Sandra L. Kane-Gill, PharmD., MSc.– Nothing to disclose

Arthur P. Wheeler, MD– Consultant, Speakers Bureau- Sanofi-Aventis; Consultant- Astra Zeneca

Printer settings may vary. Please use landscape layout option.